Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 8 (August)

1. The value of a preoperative ventilation-perfusion scan in patient selection for pneumonectomy.
   Interact Cardiovasc Thorac Surg, 6(4): 561-2. [Abstract] [Full-text]
2. Management and surgical resection for tracheobronchial tumors institutional experience with 12 patients.
   Interact Cardiovasc Thorac Surg, 6(4): 484-9. [Abstract] [Full-text]
3. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.
   Interact Cardiovasc Thorac Surg, 6(4): 474-8. [Abstract] [Full-text]
4. Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer.
   Interact Cardiovasc Thorac Surg, 6(4): 433-6. [Abstract] [Full-text]
5. Combined liver and lung metastasectomy through an exclusive transthoracic approach.
   J Surg Oncol, 96(2): 178-82. [Abstract] [Full-text]
6. Origin and prognostic value of circulating KRAS mutations in lung cancer patients.
   Cancer Lett, 254(2): 265-73. [Abstract] [Full-text]
7. Amrubicin for non-small-cell lung cancer and small-cell lung cancer.
   Invest New Drugs, 25(5): 499-504. [Abstract] [Full-text]
8. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database.
   Cancer, 110(4): 911-7. [Abstract] [Full-text]
9. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
   Cancer, 110(4): 845-53. [Abstract] [Full-text]
10. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Cancer, 110(4): 835-44. [Abstract] [Full-text]
11. Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
    J Clin Oncol, 25(23): 3448-55. [Abstract] [Full-text]
12. Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
    Cancer Chemother Pharmacol, 60(5): 725-32. [Abstract] [Full-text]
13. Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation.
    Cancer Chemother Pharmacol, 60(5): 681-91. [Abstract] [Full-text]
14. Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.
    Cancer Lett, 255(1): 85-94. [Abstract] [Full-text]
15. Prophylactic cranial irradiation in extensive small-cell lung cancer.
    N Engl J Med, 357(7): 664-72. [Abstract] [Full-text]
16. p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment.
    Clin Cancer Res, 13(16): 4900-8. [Abstract] [Full-text]
17. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Clin Cancer Res, 13(16): 4825-31. [Abstract] [Full-text]
18. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Clin Cancer Res, 13(16): 4759-68. [Abstract] [Full-text]
19. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways.
    Clin Cancer Res, 13(16): 4686-94. [Abstract] [Full-text]
20. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.
    J Natl Cancer Inst, 99(16): 1257-69. [Abstract] [Full-text]
21. LKB1 modulates lung cancer differentiation and metastasis.
    Nature, 448(7155): 807-10. [Abstract] [Full-text]
22. Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes.
    Food Chem Toxicol, 45(10): 2005-13. [Abstract] [Full-text]
23. Reliability of cytologic diagnosis of early lung cancer.
    Cancer, 111(4): 252-8. [Abstract] [Full-text]
24. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response.
    Occup Environ Med, 64(9): 616-25. [Abstract] [Full-text]
25. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area.
    Occup Environ Med, 64(9): 609-15. [Abstract] [Full-text]
26. Cancer mortality in a synthetic spinning plant in Besançon, France.
    Occup Environ Med, 64(9): 575-81. [Abstract] [Full-text]
27. Short schedule of cisplatin and vinorelbine: a dose-finding study in non-small-cell lung cancer.
    Oncology, 71(3): 229-36. [Abstract] [Full-text]
28. Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.
    Am J Respir Crit Care Med, 176(5): 505-12. [Abstract] [Full-text]
29. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
    Ann Thorac Surg, 84(3): 1059-65. [Abstract] [Full-text]
30. Transaortic fine-needle aspiration of centrally located lung cancer under endoscopic ultrasound guidance: the final frontier.
    Ann Thorac Surg, 84(3): 1019-21. [Abstract] [Full-text]
31. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis.
    Ann Thorac Surg, 84(3): 973-80. [Abstract] [Full-text]
32. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening.
    Ann Thorac Surg, 84(3): 959-65; discussion 965-6. [Abstract] [Full-text]
33. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
    Ann Thorac Surg, 84(3): 952-8. [Abstract] [Full-text]
34. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
    Ann Thorac Surg, 84(3): 946-50. [Abstract] [Full-text]
35. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer.
    Ann Thorac Surg, 84(3): 940-5. [Abstract] [Full-text]
36. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Ann Thorac Surg, 84(3): 934-8; discussion 939. [Abstract] [Full-text]
37. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
    Ann Thorac Surg, 84(3): 926-32; discussion 932-3. [Abstract] [Full-text]
38. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells.
    Int J Cancer, 121(8): 1690-6. [Abstract] [Full-text]
39. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
    Cancer Immunol Immunother, 56(11): 1817-29. [Abstract] [Full-text]
40. T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies.
    Cancer Immunol Immunother, 56(11): 1701-10. [Abstract] [Full-text]
41. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    J Thorac Cardiovasc Surg, 134(3): 638-43. [Abstract] [Full-text]
42. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients.
    J Thorac Cardiovasc Surg, 134(3): 630-7. [Abstract] [Full-text]
43. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease?
    J Thorac Cardiovasc Surg, 134(3): 619-23. [Abstract] [Full-text]
44. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
    Nat Clin Pract Oncol, 4(9): 551-4. [Abstract] [Full-text]
45. Prevalence and specificity of LKB1 genetic alterations in lung cancers.
    Oncogene, 26(40): 5911-8. [Abstract] [Full-text]
46. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
    Oncogene, 26(40): 5900-10. [Abstract] [Full-text]
47. Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer: retrospective analysis focused on a histological subgroup.
    Surg Endosc, 21(9): 1607-11. [Abstract] [Full-text]
48. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    J Clin Oncol, 25(25): 3952-7. [Abstract] [Full-text]
49. Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
    J Clin Oncol, 25(25): 3945-51. [Abstract] [Full-text]
50. Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
    J Clin Oncol, 25(25): 3936-44. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.